Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Sawitzki

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
European Journal of Immunology|July 29, 2025
Aging and Viral Evolution Impair Immunity Against Dominant Pan-Coronavirus-Reactive T Cell EpitopeLucie Loyal, Karsten Jürchott, Ulf Reimer, et al.
Kidney International|October 28, 2022
A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipientsAurélie Moreau, Delphine Kervella, Laurence Bouchet-Delbos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2011
Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipientsJames A Hutchinson, Paloma Riquelme, Birgit Sawitzki, et al.
Cell Reports. Medicine|May 12, 2021
Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infectionMikael Roussel, Juliette Ferrant, Florian Reizine, et al.
Nature Communications|August 12, 2021
Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19Geraldine Nouailles, Emanuel Wyler, Peter Pennitz, et al.
BMJ (Clinical Research Ed.)|October 22, 2020
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialAndy Roemhild, Natalie Maureen Otto, Guido Moll, et al.
Science Translational Medicine|September 11, 2015
Hurdles in therapy with regulatory T cellsPiotr Trzonkowski, Rosa Bacchetta, Manuela Battaglia, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2020
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipientsPaul N Harden, David S Game, Birgit Sawitzki, et al.
JCI Insight|December 7, 2018
A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studiesSabine Ivison, Mehrnoush Malek, Rosa V Garcia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2022
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimodLil Meyer-Arndt, Julian Braun, Florent Fauchere, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
European Journal of Immunology|July 29, 2025
Aging and Viral Evolution Impair Immunity Against Dominant Pan-Coronavirus-Reactive T Cell EpitopeLucie Loyal, Karsten Jürchott, Ulf Reimer, et al.
Kidney International|October 28, 2022
A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipientsAurélie Moreau, Delphine Kervella, Laurence Bouchet-Delbos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2011
Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipientsJames A Hutchinson, Paloma Riquelme, Birgit Sawitzki, et al.
Cell Reports. Medicine|May 12, 2021
Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infectionMikael Roussel, Juliette Ferrant, Florian Reizine, et al.
Nature Communications|August 12, 2021
Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19Geraldine Nouailles, Emanuel Wyler, Peter Pennitz, et al.
BMJ (Clinical Research Ed.)|October 22, 2020
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialAndy Roemhild, Natalie Maureen Otto, Guido Moll, et al.
Science Translational Medicine|September 11, 2015
Hurdles in therapy with regulatory T cellsPiotr Trzonkowski, Rosa Bacchetta, Manuela Battaglia, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2020
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipientsPaul N Harden, David S Game, Birgit Sawitzki, et al.
JCI Insight|December 7, 2018
A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studiesSabine Ivison, Mehrnoush Malek, Rosa V Garcia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2022
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimodLil Meyer-Arndt, Julian Braun, Florent Fauchere, et al.
Pageof 14